Since CD19 and BCR/BTK signaling are both proliferative pathways for B cell malignancies, we next sought to determine whether BCR signaling plays a functional role in CD19-resistant B-ALL. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.